The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

simaerep: Find Clinical Trial Sites Under-Reporting Adverse Events

Monitoring of Adverse Event (AE) reporting in clinical trials is important for patient safety. Sites that are under-reporting AEs can be detected using Bootstrap-based simulations that simulate overall AE reporting. Based on the simulation an AE under-reporting probability is assigned to each site in a given trial (Koneswarakantha 2021 <doi:10.1007/s40264-020-01011-5>).

Version: 0.6.0
Depends: R (≥ 4.0), ggplot2
Imports: dplyr (≥ 1.0.0), tidyr (≥ 1.1.0), magrittr, purrr, rlang, stringr, forcats, cowplot, RColorBrewer, furrr (≥ 0.2.1), progressr, knitr, tibble, dbplyr
Suggests: testthat, devtools, pkgdown, spelling, haven, vdiffr, lintr, DBI, duckdb, ggExtra
Published: 2024-09-30
DOI: 10.32614/CRAN.package.simaerep
Author: Bjoern Koneswarakantha ORCID iD [aut, cre, cph], F. Hoffmann-La Roche Ltd [cph]
Maintainer: Bjoern Koneswarakantha <bjoern.koneswarakantha at roche.com>
License: MIT + file LICENSE
URL: https://openpharma.github.io/simaerep/, https://github.com/openpharma/simaerep/
NeedsCompilation: no
Language: en-US
Materials: README NEWS
CRAN checks: simaerep results

Documentation:

Reference manual: simaerep.pdf

Downloads:

Package source: simaerep_0.6.0.tar.gz
Windows binaries: r-devel: simaerep_0.6.0.zip, r-release: simaerep_0.6.0.zip, r-oldrel: simaerep_0.6.0.zip
macOS binaries: r-release (arm64): simaerep_0.6.0.tgz, r-oldrel (arm64): simaerep_0.6.0.tgz, r-release (x86_64): simaerep_0.6.0.tgz, r-oldrel (x86_64): simaerep_0.6.0.tgz
Old sources: simaerep archive

Linking:

Please use the canonical form https://CRAN.R-project.org/package=simaerep to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.